|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/727 | |
| A61P 7/02 |
| (11) | Number of the document | 1807095 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05824840.2 |
| Date of filing the European patent application | 2005-10-26 | |
| (97) | Date of publication of the European application | 2007-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-05-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/039011 |
| Date | 2005-10-26 |
| (87) | Number | WO 2006/047755 |
| Date | 2006-05-04 |
| (30) | Number | Date | Country code |
| 974566 | 2004-10-27 | US |
| (72) |
WALENGA, Jeanine, M., US
KENNEDY, Thomas, Preston, US
|
| (73) |
Paringenix, Inc.,
101 N. Wilmot Road, Suite 600, Tucson, AZ 85711,
US
|
| (54) | 2-O, 3-O DESULFATED HEPARIN FOR THE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) SYNDROME |
| 2-O, 3-O DESULFATED HEPARIN FOR THE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) SYNDROME |